AUM $8.72BER 0.44%NAV $183.61Holdings 250Inception Feb 2001
Price Chart
Key Statistics
Previous Close
$183.67Day Range
$183.51$188.69
52-Week Range
$126.47$187.36
Avg Volume
1.6MDividend Yield
0.23%Expense Ratio
0.44%AUM
$8.72BShares Outstanding
46.7METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 85.90% |
| Netherlands | 4.23% |
| Denmark | 2.41% |
| Switzerland | 2.18% |
| United Kingdom | 1.83% |
| Ireland | 0.83% |
| Canada | 0.70% |
| Germany | 0.66% |
| France | 0.49% |
| Spain | 0.13% |
| China | 0.13% |
| Other | 0.13% |
| Belgium | 0.10% |
| Australia | 0.09% |
| Singapore | 0.08% |
| Italy | 0.08% |
| Luxembourg | 0.03% |
| Taiwan | 0.00% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Similar ETFs
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by iShares that launched on Feb 5, 2001. It currently manages $8.72B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 250 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 45.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC | 8.10% | 1,469,024 | $698.1M |
| 2 | AMGN | AMGEN INC | 7.96% | 1,952,105 | $686.0M |
| 3 | GILD | GILEAD SCIENCES INC | 7.10% | 4,890,638 | $612.1M |
| 4 | REGN | REGENERON PHARMACEUTICALS INC | 5.14% | 710,572 | $443.0M |
| 5 | ARGX | ARGENX SE ADR | 3.62% | 365,867 | $311.9M |
| 6 | ALNY | ALNYLAM PHARMACEUTICALS INC | 3.19% | 936,258 | $275.3M |
| 7 | NTRA | NATERA INC | 2.90% | 961,611 | $250.0M |
| 8 | RVMD | REVOLUTION MEDICINES INC | 2.64% | 1,340,652 | $227.6M |
| 9 | BIIB | BIOGEN INC | 2.39% | 1,030,654 | $205.7M |
| 10 | ILMN | ILLUMINA INC | 2.16% | 1,062,644 | $186.1M |
| 11 | UTHR | UNITED THERAPEUTICS CORP | 1.84% | 288,976 | $158.9M |
| 12 | INSM | INSMED INC | 1.81% | 1,511,773 | $156.4M |
| 13 | ONC | BEONE MEDICINES AG | 1.80% | 560,640 | $155.4M |
| 14 | MRNA | MODERNA INC | 1.79% | 2,558,549 | $154.6M |
| 15 | INCY | INCYTE CORP | 1.75% | 1,393,827 | $151.2M |
Page 1 of 5
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +1.10% | |
| 1W | +5.85% | |
| 1M | +8.78% | |
| 3M | +15.75% | |
| 6M | +9.72% | |
| YTD | +10.86% | |
| 1Y | +48.15% | |
| 3Y | +48.76% | |
| 5Y | +14.68% |
Moving Averages
20-Day MA
$172.75
Above 20-Day MA50-Day MA
$171.25
Above 50-Day MA200-Day MA
$165.48
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$187.36
Current Price
$185.64
52-Week Low
$126.47
$126.47$187.36
Current Yield
0.23%
Annual Dividend
$0.5118
Frequency
Quarterlyx/year
Last Ex-Date
Jun 15, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Jun 15, 2026 | $0.0238 | Jun 18, 2026 |
| Mar 17, 2026 | $0.1218 | Mar 20, 2026 |
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
| Dec 13, 2022 | $0.1010 | Dec 19, 2022 |
| Sep 26, 2022 | $0.1590 | Sep 30, 2022 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Healthcare(175 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.62% | 0.83% |
| AUM | $8.72B | $945.4M | $1.61B |
| Dividend Yield | 0.23% | 3.38% | 1.97% |
| Avg Volume | 1.6M | 290.1K | 984.3K |
| Holdings | 250 | 95 | 65 |
| Performance | |||
| 1-Month Return | +11.23% | +7.17% | +9.40% |
| 6-Month Return | +7.44% | +7.11% | +13.10% |
| YTD Return | +11.02% | +9.12% | +14.47% |
| 1-Year Return | +21.51% | +16.01% | +24.53% |
Compare with Another ETF
Search for an ETF to compare with IBB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.